Australia's COVID-19 response saved countless lives, but it also left hundreds of people believing they were suffering a ...

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

Donald Trump is set to launch one of the biggest crackdowns on unhealthy eating in American history - despite being the ...

An FDA-approved vaccine for smallpox and mpox is effective but causes side effects. The other requires multiple doses. An experimental single-dose vaccine uses the horsepox virus to harness the ...

Add articles to your saved list and come back to them any time. Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

Unfortunately, little is known about MIS-C pathophysiology and the effects of vaccination on disease ... dosages of the ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

Booster doses of the original monovalent COVID-19 vaccine are associated with lower incidence of symptoms in health care personnel 6 weeks postinfection.

The stack of derivative actions against Moderna is growing in the District of Massachusetts, with the latest case challenging representations of the company's RSV vaccine's success filed on Nov. 12.